Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.

Tassev, D V

Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor. [electronic resource] - Cancer gene therapy Feb 2012 - 84-100 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5500

10.1038/cgt.2011.66 doi


Animals
Antigens, Viral--immunology
CHO Cells
Cell Line
Chimerism
Cricetinae
Epitopes, T-Lymphocyte--immunology
Epstein-Barr Virus Nuclear Antigens
HLA-A2 Antigen--genetics
Humans
Immunoglobulin Fragments--immunology
Killer Cells, Natural--immunology
Oligopeptides--immunology
Receptors, Antigen--genetics